Evidence map›Paper›PMID 38237210›Full record

ArticleInternational journal for parasitology. Drugs and drug resistance2024

Benzimidazole F167Y polymorphism in the canine hookworm, Ancylostoma caninum: Widespread geographic, seasonal, age, and breed distribution in United States and Canada dogs.

Christian M Leutenegger, Michelle D Evason, Jennifer L Willcox, Haresh Rochani, Holly L Richmond, Cathy Meeks, Cecilia E Lozoya, Jeffrey Tereski, Samantha Loo, Kelly Mitchell and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal for parasitology. Drugs and drug resistance, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
13.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Parasitology · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Christian M LeuteneggerAntech Diagnostics, Fountain Valley, CA, USA. Electronic address: christian.leutenegger@antechmail.com.
Michelle D EvasonAntech Diagnostics, Fountain Valley, CA, USA.
Jennifer L WillcoxAntech Diagnostics, Fountain Valley, CA, USA.
Haresh RochaniAntech Diagnostics, Fountain Valley, CA, USA.
Holly L RichmondAntech Diagnostics, Fountain Valley, CA, USA.
Cathy MeeksAntech Diagnostics, Fountain Valley, CA, USA.
Cecilia E LozoyaAntech Diagnostics, Fountain Valley, CA, USA.
Jeffrey TereskiAntech Diagnostics, Fountain Valley, CA, USA.
Samantha LooAntech Diagnostics, Fountain Valley, CA, USA.
Kelly MitchellAntech Diagnostics, Fountain Valley, CA, USA.
Jan AndrewsAntech Diagnostics, Fountain Valley, CA, USA.
Christian SavardBioVet Inc., Saint-Hyacinthe, Québec, Canada.
Optech (Canada) · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Surveillance data for Ancylostoma spp. and the A. caninum benzimidazole treatment resistance associated F167Y polymorphism using molecular diagnostics was obtained in a large population of dogs from the United States and Canada. Real-time PCR (qPCR) for Ancylostoma spp. and allele-specific qPCR detecting a single nucleotide polymorphism (SNP) F167Y was used in 262,872 canine stool samples collected between March and December of 2022. Ancylostoma spp. was found at an overall prevalence of 2.5% (6538/262,872), with the highest prevalence in the Southern US, 4.4% (4490/103,095), and the lowest prevalence in Canada 0.6% (101/15,829). The A. caninum F167Y polymorphism was found with the highest prevalence (13.4%, n = 46/343) in the Western US and the lowest in Canada at 4.1% (4/97). The F167Y polymorphism was detected every month over the 10-month collection period. Seasonal distribution showed a peak in June for both Ancylostoma spp. (3.08%, 547/17,775) and A. caninum F167Y (12.25%, 67/547). However, the A. caninum F167Y polymorphism prevalence was highest in September (13.9%, 119/856). Age analysis indicates a higher prevalence of both hookworm infections and occurrence of resistant isolates in puppies. The breeds with the highest F167Y polymorphism prevalence in Ancylostoma spp. detected samples were poodles (28.9%), followed by Bernese Mountain dogs (25%), Cocker spaniels (23.1%), and greyhounds (22.4%). Our data set describes widespread geographic distribution of the A. caninum benzimidazole resistance associated F167Y polymorphism in the United States and Canada, with no clear seasonality compared to the Ancylostoma spp. prevalence patterns. The F167 polymorphism was present in all geographic areas with detected hookworms, including Canada. Our study highlights that the F167Y polymorphism is represented in many dog breeds, including greyhounds.

Indexed as

AncylostomaDog DiseasesAncylostomatoideaAnimalsBenzimidazolesDogsFecesSeasonsUnited StatesBenzimidazolesAncylostoma caninumBenzimidazole resistanceF167Y polymorphismqPCRUS and CanadaWellness screening

Identifiers

PMID38237210
PMCPMC10825515
OpenAlexW4390959427

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.